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Abstract 
An active implantable chemico-rheological sensor including control electronics, a Digital Signal Processor (DSP) and an RF 
transceiver has been demonstrated. The ultra-low power system architecture achieves an energy per viscosity measurement of 
only 16.6mJ of which 56% are dedicated to the micro-rheometer, 40% to the transceiver, and 4% to the DSP. Four coins batteries 
with a capacity of 150J each (Energizer 376) enabled a life time of 28’500 cycles at 37°C. The System in Package (SiP) fits in a 
8.4mm in diameter cylinder and hence is implantable. As this generic system is fully programmable, it may further control any 
biosensor or bioactuator. 
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1. Introduction 
A rotating micro-rheometer dedicated to a glucose sensing application was designed in [1]. The biosensor was 
first designed to be implanted subcutaneously in rats in order to prove the concept. The device was composed of two 
rotors. The measurement rotor was implanted, while the other, the drive rotor, was external and integrated to a 
control unit. This configuration required to place the external unit very close to the implanted rotor in order to 
ensure an optimal control of the implant. During animal trials, it could not be fixed on the rat due to its size and 
alignment issues. Thus, prior to each measurement, anesthesia of the animal was mandatory. The lack of autonomy 
of the glucose measurement system combined to repeated anesthesia resulted in stressing the animal and in 
influencing its glycemia, hence preventing objective study in in vivo conditions of the biosensor [2]. Consequently, 
an active and autonomous implantable micro-rheometer is strongly desirable. 
2. System description 
The node has been devised to be generic and may control any kind of autonomous implantable biosensor. For the 
present application, it is composed of two parts as shown on Figure 1. The first one is the sensing node which  
 
* Corresponding author. Tel.: +41-21-6933822; fax: +41-21-6933891. 
 E-mail address: leandre.bolomey@epfl.ch. 
1876-6196/09 © 2009 Published by Elsevier B.V. 
doi:10.1016/j.proche.2009.07.308
Procedia Chemistry  1 (2009) 1235–1238 
Open access under CC BY-NC-ND license.
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1: System block diagram 
controls the sensor, performs the digital signal processing and RF data transmission towards the external base 
station, while the second one is specific to the biosensor front-end, i.e. the micro-rheometer. This SiP is 
encapsulated in a 8.4mm in diameter biocompatible cylindrical casing hence allowing its subcutaneous implantation, 
e.g. in an adult rat. 
2.1. Generic implantable sensing node 
The node is configured as a slave and may be woken up by a 2.45GHz signal originated from the base station. 
This feature enables ultra low power consumption in sleep mode. Once the transceiver is awake, it establishes the 
Medical Implant Communications Service link (MICS) with the base station and powers the DSP up. 
All the SiP components have been selected for their small footprint, their ultra-low power consumption and their 
high performance. Ultra-low power is mandatory as it figures the size of the batteries, the most cumbersome 
component. High performance is essential to maintain the system power consumption at its minimum level in two 
ways: by shortening the waking time of the implant and by performing in situ digital signal processing to reduce the 
amount of data to be transmitted by RF, the most power consuming subsystem of the generic node.  
The transceiver commercialized by [3] is compliant with the MICS standard, is available as a die and achieves a 
data rate up to 800kbps at 15mW. The DSP manufactured by [4] is packaged as a bumped die, is equipped with a 
dual-MAC 24-bit core combined to a configurable accelerator and exhibit 1mW at 5MHz system clock. Figure 2 
shows the node prototype. This SiP encompasses 25 components mounted on a flexible PCB that is folded in order 
to reduce the volume occupancy of node electronics. 
2.2. Micro-rheometer 
The micro-rheometer is used to determine the viscosity of the sensitive fluid that linearly depends on the glucose 
concentration level. The measurement consists in accelerating a cylindrical magnet by the means of a three-phase 
coil and measuring its deceleration over time with an angular Hall sensor. The viscosity is then computed by the 
DSP by extracting the damping factor.  
All the components of this biosensor have been chosen to optimize the power consumption. The die packaged 
angular Hall sensor developed by [5] operates at 1.8V and consumes only 2.9mW. The miniature coil exhibits a very 
low time constant (1.36us) unsuitable for a switching current control method. Consequently, the coil current is 
 
 
 
 
 
 
Figure 2: Generic implantable sensing node prototype 
 
 
 
 
 
 
 
Figure 3: Micro-rheometer prototype 
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 supplied by a high efficiency DFN packaged DC/DC converter featuring an 0.82V output voltage. This low coil 
voltage implies that the bridge driver is made of very low threshold voltage MOSFET. Bumped die version of these 
transistors were used. Figure 3 depicts the micro-rheometer prototype. 
 
 
 
 
 
 
 
Figure 4: System operation 
3.  Biosensor operations 
The micro-rheometer requires the calibration of the 6 coil phase angular positions for proper magnet acceleration. 
This calibration is performed only once and the reference positions are stored in the non-volatile memory. As the 
system computes the angular speed, it is very sensitive to the non-linearity of the angular Hall sensor. Therefore a 
calibration procedure is also required to linearize the sensor data. This calibration is stored as a look-up table in the 
non-volatile memory.  
A measurement starts once the MICS transceiver is woken up. The DSP is powered up and its Power-On-Reset 
sequence begins followed by the application loading from the non-volatile memory. The application accelerates then 
the magnet up to a reference rotation frequency (typically 220Hz) by controlling the coil with the angular Hall 
sensor information and the calibrated coil phase positions. After 100ms, the acceleration is switched off and the 
magnet which freely evolves, decelerates. During this phase, the angular position is acquired by the DSP A/D 
converter. The data are linearized with the calibration look-up table and the angular speed is computed with a three-
point estimation algorithm. These speed data need to be filtered, because they contain some wrong values between 
two turns due to the discontinuous output of the angular position. The filtered speed data are then used to compute 
their logarithm and the partial results for the general linear regression algorithm. The deceleration measurement 
phase lasts until the magnet speed goes down to 100Hz; below this speed the earth magnetic field influences the 
deceleration. Once the deceleration is complete, the damping factor is computed from the partial results of the 
general linear regression algorithm. The temperature is also measured, and is sent with the damping factor through 
the MICS link. When the data are received on the base station, the system goes back to sleep mode. The operations 
sequence is represented on figure 4. 
4. Power consumption 
To reach the tight diameter of the system, we selected silver-oxide coin type batteries available in 6.8mm in 
diameter. Due to the high internal resistance of this kind of batteries, four of them were required to provide the 
power necessary to magnet acceleration phase. We assessed the life time for different batteries at 37°C in viscosity 
Figure 5: Test of 3 batteries of different manufacturer at 37°C 
 
 
 
 
 
 
 
 
 
 
Figure 6: System power consumption during a viscosity measurement; 1: 
POR and application loading; 2: acceleration; 3: measurement 
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 measurement conditions. This is reported on Figure 5. The most suitable battery was the Energizer 376/377 that has 
sustained 35’000 cycles.  
The power consumption of the overall system is reported on Figure 6. For this measurement, we used a current to 
voltage converter with a shunt resistor of 1Ohm and a gain of 100. A peek current of 33mA occurs during the 
acceleration phase. The measurement lasts 532ms and the energy for one measurement is only 16.56mJ. The energy 
consumption of the parts of the system for the different phases is reported on Figure 7. 56% of the energy is 
consumed by the Hall sensor and magnet acceleration, 40% by the MICS transceiver and only 4% by the DSP. The 
sleep state consumes 1.8uW and lasts 15 minutes. If we include it, for one measurement, the sleep phase represents 
9% of the energy. The system has been assessed with real batteries at 37°C with an accelerated measurement period 
of 15s. The result is shown on Figure 8. The life time for the measurement was 28’500 cycles. In the end, the energy 
for accelerating the magnet was no longer sufficient. 
5. Conclusion 
An implantable generic ultra-low power system with DSP capabilities has been demonstrated through a miniature 
chemico-rheological biosensor designed for a continuous glucose sensing application. The implantable biosensor 
mean current consumption is only 6.8uA, with a 3V power supply with a measurement every 15 minutes. The SiP 
fits in a 8.4mm in diameter cylinder and thus is implantable for animal trial. The last step of this study is to integrate 
a miniaturized version of the MICS and 2.45GHz dual band antenna developed in [6] to the generic system and to 
encapsulate the overall system with a biocompatible housing to enable long term subcutaneous implantation. 
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Figure 7: Components energy consumption 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: System life time 
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